For cluster 22, the cells were defined through the expression of CD8+, CD39+, CD223+ (Lag-3), CD62L−, GrzB+, and IFNγ, indicating activated CD8+ T cells capable of tumor killing function. This evidence concerns the gene CD8A and neoplasm.